Stephen Gomperts, MD, PhD, is a member of the Clinical Core of the Massachusetts Alzheimer’s Disease Research Center (MADRC), and the Director of the Lewy Body Dementia Unit at Massachusetts General Hospital. His translational and clinical research focuses on molecular imaging  and therapeutic development for Parkinson’s disease and dementia with Lewy bodies. He is principal investigator on a funded study to image epigenetic processes in Parkinson's using [11C]Martinostat as well as on several current grants evaluating PET imaging agents of beta-amyloid and tau and a small molecule therapeutic for Parkinson's.

Dr. Gomperts received his medical degree and doctorate at UC San Francisco School of Medicine. He went on to complete his residency at Brigham and Women's Hospital and a fellowship at Massachusetts General Hospital. He is a board-certified neurologist.